Office of Technology Development


The Office of Technology Development

Our 2021 work to date
  • 134 Invention Disclosures
  • 178 Patent Applications
  • 59 Patents Issued

The Office of Technology Development manages Memorial Sloan Kettering’s world-class portfolio of intellectual property. We are responsible for:

  • Identifying and evaluating new inventions
  • Seeking patent protection
  • Developing, managing, and commercializing the institution’s innovations
  • Facilitating start-up creation.

The goal of our technology transfer activities is to ensure that scientific research at Memorial Sloan Kettering is developed and applied for the common good.

For legal support relating to intellectual property  and pre-clinical or clinical research agreements, contact a member of our Legal team.

  • About Us

    The Office of Technology Development’s mission is to ensure that Memorial Sloan Kettering’s inventions have the greatest chance of benefiting patients.

  • Our Staff

    The office is staffed by technology transfer professionals with backgrounds in science, intellectual property, and business development.

  • Success Stories

    Research conducted at Memorial Sloan Kettering has produced ten drugs FDA approved for marketing, and one product approved by the USDA.

  • Technologies Available for Licensing

    We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.

  • Digital Health Projects

    Summary goes here

  • Tangible Materials Available for Licensing

    We have an extensive collection of tangible research materials, including cell lines, antibodies, reagents, and mouse models, which are available for licensing on a non-exclusive basis for research and commercial purposes.

  • Contact OTD

    Learn more about how to reach us by phone, e-mail, regular mail, or courier.

For MSK Investigators

View the Office of Technology Development’s Intranet page.